Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Manfred, Danilovits"'
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines
Autor:
Manfred Danilovits, Patovirta Rl, Lea Pehme, Aaltonen Hk, Grierson S, Vasankari T, Vauhkonen M, Piret Viiklepp, Feuth T
Publikováno v:
The International Journal of Tuberculosis and Lung Disease
BACKGROUND: Multidrug-resistant TB (MDR-TB) is a growing problem in the effort to end the global TB epidemic. In 2019, the WHO adopted a new standardised regiment for MDR-TB, consisting of only oral medications.METHODS: We estimated the impact of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811cf043d76fc76ce4cbca60b54828b0
http://europepmc.org/articles/PMC8259121
http://europepmc.org/articles/PMC8259121
Autor:
Eva Nathanson, Catharina Lambregts-van Weezenbeek, Michael Rich, Rajesh Gupta, Jaime Bayona, Kai Blöndal, José A. Caminero, J. Peter Cegielski, Manfred Danilovits, Marcos A. Espinal, Vahur Hollo, Ernesto Jaramillo, Vaira Leimane, Carole D. Mitnick, Joia S. Mukherjee, Paul Nunn, Alexander Pasechnikov, Thelma E. Tupasi, Charles Wells, Mario C. Raviglione
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 9, Pp 1389-1397 (2006)
Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philip
Externí odkaz:
https://doaj.org/article/31f5914dcfb44911a842b9a4fcafdbba
Autor:
Philippe Moris, Shih-Lung Cheng, Manfred Danilovits, Wei-Juin Su, Paul Gillard, Marcela Castro, Anne Bollaerts, Opokua Ofori-Anyinam, Pan-Chyr Yang, Lea Pehme, Erik Jongert, Marie-Ange Demoitié
Publikováno v:
Tuberculosis. 100:118-127
Summary Previous studies have shown that the M72/AS01 E candidate tuberculosis vaccine is immunogenic with a clinically acceptable safety profile in healthy and Mycobacterium tuberculosis -infected adults. This phase II, observer-blind, randomised st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7893defabf30bd71947a9a5dcbd8f6bb
Autor:
Alexander S, Pym, Andreas H, Diacon, Shen-Jie, Tang, Francesca, Conradie, Manfred, Danilovits, Charoen, Chuchottaworn, Irina, Vasilyeva, Koen, Andries, Nyasha, Bakare, Tine, De Marez, Myriam, Haxaire-Theeuwes, Nacer, Lounis, Paul, Meyvisch, Ben, Van Baelen, Rolf P G, van Heeswijk, Brian, Dannemann, Xia, Zhang
Publikováno v:
European Respiratory Journal. 47:564-574
Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase 2 trial (TMC207-C208; NCT00449644). The current phase 2, multicenter, open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff1a02d794789f230b1e419e42384b2
https://doi.org/10.1183/13993003.00724-2015
https://doi.org/10.1183/13993003.00724-2015
Autor:
Frank van Leth, Manfred Danilovits, Veronika Polcova, Simon Tiberi, Neus Altet, Inge Muylle, Wiel C M de Lange, Raisa Barbuta, Vaira Leimane, for Tbnet, Heinke Kunst, Ana Ciobanu, Victor Spinu, Sofia Alexandru, Varvara Solodovnikova, Rudolf Rumetshofer, Gunar Günther, Gina Gualano, Cristina Popa, Korkut Avsar, Christoph Lange, Alena Skrahina, Raquel Duarte, Valeriu Crudu, Martin Dedicoat, Graham H. Bothamley, Piret Viiklepp, Cecile Magis-Escurra, Anne Marie McLaughlin, Didi Bang
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 198(3), 379-386. AMER THORACIC SOC
American Journal of Respiratory and Critical Care Medicine, 198, 3, pp. 379-386
American journal of respiratory and critical care medicine, 198(3), 379-386. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 198, 379-386
American Journal of Respiratory and Critical Care Medicine, 198, 3, pp. 379-386
American journal of respiratory and critical care medicine, 198(3), 379-386. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 198, 379-386
Rationale: Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in Europe. Reported treatment success rates are around 50% or less, and cure rates are even lower.Objectives: To document the management and treatment outcome in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::602058dfc24afc2daebf8cfd2f5b0f96
https://research.rug.nl/en/publications/39e9ffb4-675a-4322-988f-8c5e2f9ca7c2
https://research.rug.nl/en/publications/39e9ffb4-675a-4322-988f-8c5e2f9ca7c2
Autor:
Yanina Balabanova, Birute Radiulyte, Olga Ignatyeva, Kaadri Jaama, Edita Davidaviciene, Francis Drobniewski, Vija Riekstina, Manfred Danilovits, Lena Fiebig, Christina Popa, Vladyslav Nikolayevskyy
Publikováno v:
Thorax. 72(9)
WHO recently recommended the use of a shorter multidrug-resistant TB (MDR-TB) regimen under programmatic conditions. We assessed eligibility for this regimen in a cohort of 737 adult patients with MDR-TB from Latvia, Lithuania, Estonia and Bucharest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5977bfe1e7c82eec5f1e08f20ddecf3d
https://pubmed.ncbi.nlm.nih.gov/28442556
https://pubmed.ncbi.nlm.nih.gov/28442556
Autor:
Manfred Danilovits, Anu Kurve, Charles D. Wells, Tiina Kummik, Klavdia Levina, Davide Manissero, Lawrence Geiter, Lea Pehme, Tarmo Tomson, Vaira Leimane, Girts Skenders, Andra Cirule, Vija Skripconoka
Publikováno v:
The European Respiratory Journal
Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d62247d67572a53df62d6f8e514c226
https://doi.org/10.1183/09031936.00125812
https://doi.org/10.1183/09031936.00125812
Autor:
Wieslaw Jakobowiak, Nina Khurieva, Peremitin Gg, Rosella Centis, Manfred Danilovits, Giovanni Battista Migliori, Katherine Floyd, Raymond Hutubessy, Kai Kliiman, Salmaan Keshavjee
Publikováno v:
European Respiratory Journal. 40:133-142
Evidence on the cost and cost-effectiveness of treatment of multidrug-resistant tuberculosis (MDR-TB) is limited, and no published data are available from former Soviet Union countries, where rates of MDR-TB are highest globally. We evaluated the cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554ad4da4d2f21f2195fbb9c387691c0
https://doi.org/10.1183/09031936.00169411
https://doi.org/10.1183/09031936.00169411
Autor:
R. Loddenkemper, Hans Kluge, Keertan Dheda, Timothy R. Aksamit, Davide Manissero, Jadwiga A. Wedzicha, Manfred Danilovits, Maryse Wanlin, Vaira Leimane, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello, G. De Vries, Christoph Lange, Francesco Blasi, Miguel Villar, Mario C. Raviglione, Giovanni Sotgiu, Anh Tuan Dinh-Xuan, O. Menegale, Laurent P. Nicod, Masoud Dara, Alimuddin Zumla, Ibrahim Abubakar, Kai Kliiman, Jose A. Caminero, Giovanni Battista Migliori, Daniela Maria Cirillo, A. Sandgren, Elmira Ibraim, E. Huitric, Jean-Pierre Zellweger, Vibeke Østergaard Thomsen
Publikováno v:
European Respiratory Journal; Vol 39
The European Respiratory Journal
European Respiratory Journal, vol. 39, no. 4, pp. 807-819
European Respiratory Journal
The European Respiratory Journal
European Respiratory Journal, vol. 39, no. 4, pp. 807-819
European Respiratory Journal
The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) jointly developed European Union Standards for Tuberculosis Care (ESTC) aimed at providing European Union (EU)-tailored standards for the diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fef4a29fccf3f6801d2b9744a6812d
Autor:
Frank van Leth, Gunar Günther, Harald Hoffmann, Christoph Lange, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits, Martin Dedicoat, Raquel Duarte, Mathilde Fréchet-Jachym, Gina Gualano, Lorenzo Guglielmetti, Jan Heyckendorf, Barbara Kalsdorf, Heinke Kunst, Wiel de Lange, Damien Le Dû, Vaira Leimane, Rita Macedo, Cecile Magis-Escurra, Anne-Marie McLaughlin, Inge Muylle, Ioana D. Olaru, Olena Oliveira, Veronika Polcová, Emanuele Pontali, Cristina Popa, Jérôme Robert, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Nicolas Veziris, Piret Viiklepp
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 196, 11, pp. 1489-1490
American journal of respiratory and critical care medicine, 196(11), 1489-1490. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 196, 1489-1490
American journal of respiratory and critical care medicine, 196(11), 1489-1490. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 196, 1489-1490
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841b2771f841be0db13ca61cd336dd70
https://doi.org/10.1164/rccm.201705-0995le
https://doi.org/10.1164/rccm.201705-0995le